AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.
The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
It serves hospitals, acute care facilities, and outpatient imaging centers.
The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors.
IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Country | United States |
IPO Date | Jul 16, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 148 |
CEO | Roger E. Susi |
Contact Details
Address: 1025 Willa Springs Drive Winter Springs, Florida United States | |
Website | https://www.iradimed.com |
Stock Details
Ticker Symbol | IRMD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001325618 |
CUSIP Number | 46266A109 |
ISIN Number | US46266A1097 |
Employer ID | 73-1408526 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Roger E. Susi | Founder, Chairman, Chief Executive Officer & President |
John F. Glenn | Chief Financial Officer & Corporate Secretary |
Chris Williamson | Executive Vice President of Continuous Improvement & Information Technology |
Lynn Neuhardt | Vice President of Research & Development |
Matt Garner | Controller |
Randy Waddell | Vice President of Worldwide Sales & Marketing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 10, 2025 | 8-K | Current Report |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 10, 2024 | 4 | Filing |
Dec 10, 2024 | 4 | Filing |
Dec 10, 2024 | 4 | Filing |